E179 David offers the latest insights into Venture and then Paul interviews Leigh Hsu, CEO of Atticus Pharma
No se pudo agregar al carrito
Add to Cart failed.
Error al Agregar a Lista de Deseos.
Error al eliminar de la lista de deseos.
Error al añadir a tu biblioteca
Error al seguir el podcast
Error al dejar de seguir el podcast
E179 David offers the latest insights into Venture and then Paul interviews Leigh Hsu, CEO of Atticus Pharma
-
Narrado por:
-
De:
S4:E179 David offers the latest insights into venture and then Paul interviews Leigh Hsu, CEO of Atticus Pharma, a specialist BioTech Startup focused on Immunodermatology therapeutics. Atticus is utilizing a unique proprietary sustained-release skin delivery technology to address 2 specific skin conditions for which there is no good treatment. Atticus was spun out of Zylo Therapeutics who developed the skin drug delivery technology that Atticus is using for FDA regulated candidate drugs, one for cutaneous Lupus and the other for Alopecia (localized hair loss). (interview recorded 6.11.25)
Follow David and Paul:
https://x.com/DGRollingSouth
https://x.com/PalmettoAngel
Connect On LinkedIn:
https://www.linkedin.com/in/davidgrisell/
https://www.linkedin.com/in/paulclarkprivateequity/
We invite your feedback and suggestions at www.ventureinthesouth.com or email david@ventureinthesouth.com. Learn more about RollingSouth at rollingsouth.vc or email david@rollingsouth.vc.